Thymic humoral factor-γ2 (THF-γ2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapy

Rachel Ophir*, Marit Pecht, Yona Keisari, Gloria Rashid, Sylvie Lourie, Asher Meshorer, Shlomo Ben-Efraim, Nathan Trainin, Yigal Burstein

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Thymic humoral factor-γ2 (THF-γ2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry